CMS will hold the first of its monthly meetings on the unwinding of the COVID-19 public health emergency on Wednesday as an FDA panel on Monday laid out plans to discuss COVID-19 shots for those under the age of 5. Also on Wednesday FDA officials and baby formula manufacturers will go before the House Energy & Commerce oversight subcommittee following the White House’s announcement of two infant formula Defense Production Act authorizations. The current PHE is slated to last through...